6El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma[J]. Gastroenterology, 2012, 142 (6): 1264-1273.
7Said A, Wells J. Management of hepatocellular carcinoma[J]. Minerva Med, 2009, 100 ( 1 ): 51-68.
8Llovet JM, Real MI, Montafia X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial[J]. Lancet, 2002, 359(9319): 1734-1739.
9European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer. EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma[J]. J Hepatol, 2012, 56(6): 908-943.
10Grieco A, Pompili M, Gaminiti G, et al. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparision of Okuda, CLIP, and BCLC staging systems in a single Italian centre[J]. Gut, 2005, 54:411-418.
